Dexcom G7 CGM device for type 1 diabetes

Introducing the Dexcom G7 CGM device

Powerfully simple glucose monitoring

  • Learn More
Our most powerful CGM designed for greater diabetes control

Accurate glucose numbers in real-time with Dexcom G7 CGM App

Your glucose numbers, 24/7

No finger pricks*. No scanning. Accurate glucose numbers1 in real-time on your smartphone, smartwatch†† or Dexcom receiver.‡‡
*If your glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Spend more time in range with Dexcom G7 CGM App
Support to achieve your goals: lower HbA1c, more Time in Range
The new Dexcom G7 app clearly shows where your glucose levels are at, where you are heading and where you have been, helping you make more informed decisions. Spending more time in range and working to lower your HbA1c is easier than ever before.†,2,3,4,6,7
More peace of mind with Dexcom G7 Follow App
More peace of mind for your support network
You can share your numbers with up to 10 people using the Dexcom Follow app. Nice to know people have your back.2,##
Stay in control with Dexcom G7 predictive alerts
Alerts that keep you in the know
The Dexcom G7 will alert you up to 20 minutes before you go low (Urgent Low Soon Alert) or when your glucose is high. You can personalise your alerts. Quiet. Loud. Or even delay your first high alert. Up to you.
  • Learn More about Alerts
Dexcom G7 CGM warm up twice as fast as other continuous glucose monitors
More freedom with flexibility
Our smallest and most comfortable sensor§,4 also offers the flexibility of three different wear locations. You can shower, sweat, swim without worrying about your sensor. ¶,#
Dexcom G7 CGM warm up twice as fast as other continuous glucose monitors
Fast, so you don’t need to slow down
The G7 warm up is twice as fast as any other CGM.** It offers a 12-hour grace period, so you can swap sensor when it’s convenient for you.

Adapts to your needs of the moment

Dexcom G7 CGM System for hypo unaware people with T1D

For those who are hypo unaware

The predictive glucose alert and the Dexcom Follow app (share with up to 10 people) give more peace of mind, especially if you have impaired or unawareness of hypoglycaemia. With the Dexcom G7, you can know before you go low.
Dexcom G7 CGM System is suitable for children 2 Years and older

For the younger ones

Get your child’s glucose data and alerts sent to your phone with the Dexcom Follow app, so you can keep an eye on their levels remotely, allowing them to be just like other kids on the playground.
Dexcom G7 CGM System is suitable for gestational diabetes

For those who are expecting

Growing a tiny human can be exhausting. Your diabetes management doesn’t need to be. The Dexcom G7 can help give you the power to stay in control or your diabetes throughout pregnancy.†,1
Dexcom G7 CGM Aall-in-one sensor and transmitter
Meet G7, our smallest and most intuitive CGM
The Dexcom G7 low-profile, all-in-one wearable warms up faster than any other CGM on the market,** sending real-time glucose readings automatically to a compatible smart device†† or receiver.
No finger pricks*, no scanning.
  • All-in-one sensor and transmitter
  • Compatible smart device or small receiver‡‡
*If your glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Gina P., Dexcom Warrior, wearing Dexcom G7 CGM System

“It’s a kind of confidence I’ve never had until now”

“I’m a chef, so my office is a busy kitchen. Taking a break to fingerstick was never convenient. But with Dexcom G7, I just look at my phone and know exactly how my glucose is doing. It’s a kind of confidence I’ve never had until now.”
Gina P., Dexcom Warrior
T1D, 38 Years

The Dexcom G7 is the right CGM for you if:

  • You need extra support with your diabetes management (for example children or those who are hypo unaware)
  • You do not need to connect an insulin pump

Explore the Dexcom CGM Range

We have a range of Real-Time CGMs tailored to meet your needs. Explore our products to find the right one for you.
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Results obtained with a prior generation Dexcom CGM system; similar results expected with Dexcom G7 given similar or better performance, feature sets and usability.
‡ Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions.
§ Patients reported 92% of Dexcom G7 sensors were comfortable to wear (mild, no discomfort)
‖ The G7 is approved for wear on the arm and abdomen, and ages 2-6 can also wear G7 on the upper buttocks.
¶ The Dexcom G7 sensor and transmitter are water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
# If you’re in or near the water, then your display device may need to be closer than 6 meters to get sensor readings. If you're in water, you may not get sensor readings until you get out.
** The Dexcom G7 can complete the warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
†† Display devices sold separately. For a list of compatible smart devices, please visit
‡‡ A touch screen receiver can be acquired as an optional display device.
## Dexcom G6 is indicated for persons aged 2 years and older.
1 Dexcom G7 User Guide.
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Welsh JB, et al. Diabetes Technol Ther. 2019;21(3): 128-132.
4 Welsh JB, et al. J Diabetes Sci Technol 2022: 19322968221099879.
5 Heinemann L, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391(10128):1367-1377.
6 Beck RW, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial. Ann Intern Med. 2017;167(6):365-374.
7 Martens T, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA. 2021;325(22):2262-2272

LBL-1002931 Rev001

© 2024 Dexcom, Inc. All rights reserved.

ZA flag


Change region